nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Nephropathy toxic—Etoposide—muscle cancer	0.0329	0.0329	CcSEcCtD
Cefprozil—Aplastic anaemia—Dactinomycin—muscle cancer	0.0245	0.0245	CcSEcCtD
Cefprozil—Prothrombin level increased—Doxorubicin—muscle cancer	0.0239	0.0239	CcSEcCtD
Cefprozil—Lactic dehydrogenase activity increased—Doxorubicin—muscle cancer	0.0192	0.0192	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0171	0.0171	CcSEcCtD
Cefprozil—Blood lactate dehydrogenase increased—Doxorubicin—muscle cancer	0.0169	0.0169	CcSEcCtD
Cefprozil—Pancytopenia—Dactinomycin—muscle cancer	0.0156	0.0156	CcSEcCtD
Cefprozil—Neutropenia—Dactinomycin—muscle cancer	0.0153	0.0153	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0145	0.0145	CcSEcCtD
Cefprozil—Pancytopenia—Vincristine—muscle cancer	0.0139	0.0139	CcSEcCtD
Cefprozil—Neutropenia—Vincristine—muscle cancer	0.0137	0.0137	CcSEcCtD
Cefprozil—Agranulocytosis—Dactinomycin—muscle cancer	0.0136	0.0136	CcSEcCtD
Cefprozil—Pharyngitis—Dactinomycin—muscle cancer	0.013	0.013	CcSEcCtD
Cefprozil—Erythema multiforme—Dactinomycin—muscle cancer	0.0124	0.0124	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.0124	0.0124	CcSEcCtD
Cefprozil—Erythema—Dactinomycin—muscle cancer	0.0114	0.0114	CcSEcCtD
Cefprozil—Vaginal inflammation—Methotrexate—muscle cancer	0.0113	0.0113	CcSEcCtD
Cefprozil—Pancytopenia—Etoposide—muscle cancer	0.0113	0.0113	CcSEcCtD
Cefprozil—Jaundice cholestatic—Doxorubicin—muscle cancer	0.0112	0.0112	CcSEcCtD
Cefprozil—Neutropenia—Etoposide—muscle cancer	0.0111	0.0111	CcSEcCtD
Cefprozil—Vaginal infection—Methotrexate—muscle cancer	0.0107	0.0107	CcSEcCtD
Cefprozil—Aplastic anaemia—Methotrexate—muscle cancer	0.0106	0.0106	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.0105	0.0105	CcSEcCtD
Cefprozil—Agranulocytosis—Etoposide—muscle cancer	0.00986	0.00986	CcSEcCtD
Cefprozil—Vaginal inflammation—Doxorubicin—muscle cancer	0.0098	0.0098	CcSEcCtD
Cefprozil—Colitis—Doxorubicin—muscle cancer	0.00941	0.00941	CcSEcCtD
Cefprozil—Agitation—Vincristine—muscle cancer	0.00937	0.00937	CcSEcCtD
Cefprozil—Vaginal infection—Doxorubicin—muscle cancer	0.00925	0.00925	CcSEcCtD
Cefprozil—Blood urea increased—Doxorubicin—muscle cancer	0.00925	0.00925	CcSEcCtD
Cefprozil—Aplastic anaemia—Doxorubicin—muscle cancer	0.0092	0.0092	CcSEcCtD
Cefprozil—Thrombocytopenia—Dactinomycin—muscle cancer	0.00912	0.00912	CcSEcCtD
Cefprozil—Erythema multiforme—Etoposide—muscle cancer	0.00897	0.00897	CcSEcCtD
Cefprozil—Convulsion—Vincristine—muscle cancer	0.00883	0.00883	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00871	0.00871	CcSEcCtD
Cefprozil—Anaphylactic shock—Vincristine—muscle cancer	0.00832	0.00832	CcSEcCtD
Cefprozil—Thrombocytopenia—Vincristine—muscle cancer	0.00815	0.00815	CcSEcCtD
Cefprozil—Pain—Dactinomycin—muscle cancer	0.00797	0.00797	CcSEcCtD
Cefprozil—Feeling abnormal—Dactinomycin—muscle cancer	0.00768	0.00768	CcSEcCtD
Cefprozil—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00762	0.00762	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00754	0.00754	CcSEcCtD
Cefprozil—Insomnia—Vincristine—muscle cancer	0.00753	0.00753	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.0074	0.0074	CcSEcCtD
Cefprozil—Abdominal pain—Dactinomycin—muscle cancer	0.00736	0.00736	CcSEcCtD
Cefprozil—Body temperature increased—Dactinomycin—muscle cancer	0.00736	0.00736	CcSEcCtD
Cefprozil—Convulsion—Etoposide—muscle cancer	0.00716	0.00716	CcSEcCtD
Cefprozil—Pain—Vincristine—muscle cancer	0.00712	0.00712	CcSEcCtD
Cefprozil—Eosinophilia—Methotrexate—muscle cancer	0.00703	0.00703	CcSEcCtD
Cefprozil—Hypersensitivity—Dactinomycin—muscle cancer	0.00686	0.00686	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vincristine—muscle cancer	0.00681	0.00681	CcSEcCtD
Cefprozil—Confusional state—Etoposide—muscle cancer	0.0068	0.0068	CcSEcCtD
Cefprozil—Pancytopenia—Methotrexate—muscle cancer	0.00674	0.00674	CcSEcCtD
Cefprozil—Anaphylactic shock—Etoposide—muscle cancer	0.00674	0.00674	CcSEcCtD
Cefprozil—Neutropenia—Methotrexate—muscle cancer	0.00664	0.00664	CcSEcCtD
Cefprozil—Thrombocytopenia—Etoposide—muscle cancer	0.0066	0.0066	CcSEcCtD
Cefprozil—Body temperature increased—Vincristine—muscle cancer	0.00658	0.00658	CcSEcCtD
Cefprozil—Abdominal pain—Vincristine—muscle cancer	0.00658	0.00658	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00641	0.00641	CcSEcCtD
Cefprozil—Diarrhoea—Dactinomycin—muscle cancer	0.00637	0.00637	CcSEcCtD
Cefprozil—Drowsiness—Methotrexate—muscle cancer	0.00633	0.00633	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00628	0.00628	CcSEcCtD
Cefprozil—Hypersensitivity—Vincristine—muscle cancer	0.00613	0.00613	CcSEcCtD
Cefprozil—Eosinophilia—Doxorubicin—muscle cancer	0.00609	0.00609	CcSEcCtD
Cefprozil—Somnolence—Etoposide—muscle cancer	0.00599	0.00599	CcSEcCtD
Cefprozil—Vomiting—Dactinomycin—muscle cancer	0.00592	0.00592	CcSEcCtD
Cefprozil—Agranulocytosis—Methotrexate—muscle cancer	0.00591	0.00591	CcSEcCtD
Cefprozil—Rash—Dactinomycin—muscle cancer	0.00587	0.00587	CcSEcCtD
Cefprozil—Pancytopenia—Doxorubicin—muscle cancer	0.00584	0.00584	CcSEcCtD
Cefprozil—Pain—Etoposide—muscle cancer	0.00576	0.00576	CcSEcCtD
Cefprozil—Neutropenia—Doxorubicin—muscle cancer	0.00575	0.00575	CcSEcCtD
Cefprozil—Haemoglobin—Methotrexate—muscle cancer	0.00571	0.00571	CcSEcCtD
Cefprozil—Diarrhoea—Vincristine—muscle cancer	0.00569	0.00569	CcSEcCtD
Cefprozil—Haemorrhage—Methotrexate—muscle cancer	0.00568	0.00568	CcSEcCtD
Cefprozil—Pharyngitis—Methotrexate—muscle cancer	0.00564	0.00564	CcSEcCtD
Cefprozil—Feeling abnormal—Etoposide—muscle cancer	0.00556	0.00556	CcSEcCtD
Cefprozil—Nausea—Dactinomycin—muscle cancer	0.00553	0.00553	CcSEcCtD
Cefprozil—Gastrointestinal pain—Etoposide—muscle cancer	0.00551	0.00551	CcSEcCtD
Cefprozil—Dizziness—Vincristine—muscle cancer	0.0055	0.0055	CcSEcCtD
Cefprozil—Drowsiness—Doxorubicin—muscle cancer	0.00548	0.00548	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00544	0.00544	CcSEcCtD
Cefprozil—Erythema multiforme—Methotrexate—muscle cancer	0.00537	0.00537	CcSEcCtD
Cefprozil—Urticaria—Etoposide—muscle cancer	0.00536	0.00536	CcSEcCtD
Cefprozil—Body temperature increased—Etoposide—muscle cancer	0.00533	0.00533	CcSEcCtD
Cefprozil—Abdominal pain—Etoposide—muscle cancer	0.00533	0.00533	CcSEcCtD
Cefprozil—Vomiting—Vincristine—muscle cancer	0.00529	0.00529	CcSEcCtD
Cefprozil—Rash—Vincristine—muscle cancer	0.00525	0.00525	CcSEcCtD
Cefprozil—Dermatitis—Vincristine—muscle cancer	0.00524	0.00524	CcSEcCtD
Cefprozil—Headache—Vincristine—muscle cancer	0.00521	0.00521	CcSEcCtD
Cefprozil—Agranulocytosis—Doxorubicin—muscle cancer	0.00512	0.00512	CcSEcCtD
Cefprozil—Hypersensitivity—Etoposide—muscle cancer	0.00497	0.00497	CcSEcCtD
Cefprozil—Erythema—Methotrexate—muscle cancer	0.00495	0.00495	CcSEcCtD
Cefprozil—Haemoglobin—Doxorubicin—muscle cancer	0.00495	0.00495	CcSEcCtD
Cefprozil—Nausea—Vincristine—muscle cancer	0.00494	0.00494	CcSEcCtD
Cefprozil—Haemorrhage—Doxorubicin—muscle cancer	0.00492	0.00492	CcSEcCtD
Cefprozil—Pharyngitis—Doxorubicin—muscle cancer	0.00488	0.00488	CcSEcCtD
Cefprozil—Pruritus—Etoposide—muscle cancer	0.00477	0.00477	CcSEcCtD
Cefprozil—Erythema multiforme—Doxorubicin—muscle cancer	0.00465	0.00465	CcSEcCtD
Cefprozil—Diarrhoea—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Cefprozil—Dizziness—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Cefprozil—Convulsion—Methotrexate—muscle cancer	0.00429	0.00429	CcSEcCtD
Cefprozil—Vomiting—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Cefprozil—Erythema—Doxorubicin—muscle cancer	0.00428	0.00428	CcSEcCtD
Cefprozil—Rash—Etoposide—muscle cancer	0.00425	0.00425	CcSEcCtD
Cefprozil—Dermatitis—Etoposide—muscle cancer	0.00425	0.00425	CcSEcCtD
Cefprozil—Headache—Etoposide—muscle cancer	0.00422	0.00422	CcSEcCtD
Cefprozil—Tension—Doxorubicin—muscle cancer	0.0042	0.0042	CcSEcCtD
Cefprozil—Nervousness—Doxorubicin—muscle cancer	0.00416	0.00416	CcSEcCtD
Cefprozil—Confusional state—Methotrexate—muscle cancer	0.00407	0.00407	CcSEcCtD
Cefprozil—Anaphylactic shock—Methotrexate—muscle cancer	0.00404	0.00404	CcSEcCtD
Cefprozil—Nausea—Etoposide—muscle cancer	0.004	0.004	CcSEcCtD
Cefprozil—Thrombocytopenia—Methotrexate—muscle cancer	0.00395	0.00395	CcSEcCtD
Cefprozil—Agitation—Doxorubicin—muscle cancer	0.00394	0.00394	CcSEcCtD
Cefprozil—Convulsion—Doxorubicin—muscle cancer	0.00371	0.00371	CcSEcCtD
Cefprozil—Insomnia—Methotrexate—muscle cancer	0.00365	0.00365	CcSEcCtD
Cefprozil—Somnolence—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Cefprozil—Confusional state—Doxorubicin—muscle cancer	0.00353	0.00353	CcSEcCtD
Cefprozil—Anaphylactic shock—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Cefprozil—Pain—Methotrexate—muscle cancer	0.00345	0.00345	CcSEcCtD
Cefprozil—Thrombocytopenia—Doxorubicin—muscle cancer	0.00342	0.00342	CcSEcCtD
Cefprozil—Feeling abnormal—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Cefprozil—Gastrointestinal pain—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Cefprozil—Urticaria—Methotrexate—muscle cancer	0.00321	0.00321	CcSEcCtD
Cefprozil—Abdominal pain—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Cefprozil—Body temperature increased—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Cefprozil—Insomnia—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Cefprozil—Somnolence—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Cefprozil—Pain—Doxorubicin—muscle cancer	0.00299	0.00299	CcSEcCtD
Cefprozil—Hypersensitivity—Methotrexate—muscle cancer	0.00298	0.00298	CcSEcCtD
Cefprozil—Feeling abnormal—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Cefprozil—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00286	0.00286	CcSEcCtD
Cefprozil—Pruritus—Methotrexate—muscle cancer	0.00286	0.00286	CcSEcCtD
Cefprozil—Urticaria—Doxorubicin—muscle cancer	0.00278	0.00278	CcSEcCtD
Cefprozil—Abdominal pain—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Cefprozil—Body temperature increased—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Cefprozil—Diarrhoea—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Cefprozil—Dizziness—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Cefprozil—Hypersensitivity—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Cefprozil—Vomiting—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Cefprozil—Rash—Methotrexate—muscle cancer	0.00255	0.00255	CcSEcCtD
Cefprozil—Dermatitis—Methotrexate—muscle cancer	0.00254	0.00254	CcSEcCtD
Cefprozil—Headache—Methotrexate—muscle cancer	0.00253	0.00253	CcSEcCtD
Cefprozil—Pruritus—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Nausea—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Cefprozil—Diarrhoea—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Cefprozil—Dizziness—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Cefprozil—Vomiting—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Cefprozil—Rash—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Cefprozil—Dermatitis—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Cefprozil—Headache—Doxorubicin—muscle cancer	0.00219	0.00219	CcSEcCtD
Cefprozil—Nausea—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
